Dr. Antonio Capone Jr., MD

Dr. Capone practices at Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan.

Dr. Capone's NPI, 1760411664, was assigned on July 2, 2006. Dr. Capone graduated from The Warren Alpert Medical School of Brown University in 1983. Dr. Capone holds Michigan license 4301075697.

Dr. Capone's primary practice is Beaumont Neuroscience Center - Royal Oak, at 3555 W 13 Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 551-2250.

Dr. Capone's primary practice is Beaumont Neuroscience Center - Royal Oak in Royal Oak, Michigan. Dr. Capone is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Capone to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Capone practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Capone's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Capone is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Capone's licenses on file in 5 states: Michigan, Maine, Florida, Georgia and Pennsylvania.

Dmand AI lists age-related macular degeneration, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, hypertensive retinopathy, inflammation of iris and retinal detachment among the conditions Dr. Capone treats.

CMS data shows 13,007 Medicare services from Dr. Capone across 17 procedure codes in 2024, for 403 Medicare patients. Medicare paid $1,357,772 for them. Every service was in an office.

CMS counts 403 Medicare patients who saw Dr. Capone in 2024. The largest group is 75 to 84, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Capone's median patient age at 70, with 57% women.

In 2024, Dr. Capone wrote 144 Medicare Part D claims for 45 patients. 65% of them were for generic drugs. CMS names the drug for 70 of them, across 3 drugs with 11 or more claims each, at $3,564 in total drug cost. In 2023, CMS named 52 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Capone for performance year 2024, reported as part of a group. Dr. Capone accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 216 papers to Dr. Capone, published from 2008 to 2024. 2015 was the busiest year, with 10. The most frequent topics are Visual Acuity, Vitrectomy and Retinal Detachment. Dr. Capone has published most often in Retina. Dr. Capone's most frequent co-authors are Dean Eliott, MD, Prethy Rao, MD and Omesh Parkash Gupta, MD.

CMS Open Payments shows 100 general payments to Dr. Capone from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Novartis Pharma AG paid the most, $51,758. It also lists 1 research payment totaling $6,240 in 2016.

Dmand AI lists 2 awards for Dr. Capone, most recently Regional Top Doctor in 2014.

Dr. Capone graduated from The Warren Alpert Medical School of Brown University in 1983. Dr. Capone is a member of AAO.

Dr. Capone is in network with 25 carriers, including Aetna, Health Alliance Plan and Priority Health. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.